Stryker Posts 7.7% Sales Growth, Raises Adjusted Earnings 10.3%
Quarterly organic sales rose 7.7%, while reported diluted earnings per share fell; Stryker updated its full-year outlook.
Makkler Newsroom · Oct 30, 08:03 AM · 1 min read
Stryker Corporation SYK
NYSEHealth TechnologyUnited States
$309.64-2.75 (-0.88%)
Market closed· · USD · Data may be delayed
- Day's range
- 306.55316.07
- 52-week range
- 267.00389.33
Financial health
– / 5
Analyst view · 31 firms
Buy22 buy · 9 hold · 0 sell
Avg. target $340.68 (+10.0%)
Prices may be delayed and are for informational purposes only - not investment advice.